Knowledge of Saudi Patients with Autoimmune Diseases about Hydroxychloroquine Toxicity: The Role of Physician–Patient Communication

Knowledge of Saudi Patients with Autoimmune Diseases about Hydroxychloroquine Toxicity: The Role of Physician–Patient Communication

This cross-sectional internet-based questionnaire aimed to assess the knowledge and experience of autoimmune disease patients in Saudi Arabia of the ocular effects of hydroxychloroquine (HCQ). Among the 245 respondents, discontinuation of the drug was linked to its ocular toxicity in approximately 7...

Full description

Bibliographic Details
Main Authors:	Amal Aldarwesh, Ali Almustanyir, Mazoon Alharthi, Duja Alhayan
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Pharmacy
Subjects:	autoimmune diseases hydroxychloroquine rheumatoid arthritis systemic lupus erythematosus
Online Access:	https://www.mdpi.com/2226-4787/10/6/152

Similar Items

Self-Efficacy of Saudi Patients with Autoimmune Diseases in Managing Hydroxychloroquine-Induced Ocular Complications: A Cross-Sectional Survey
by: Amal Aldarwesh, et al.
Published: (2022-03-01)

Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
by: Elizabeth Park, et al.
Published: (2021-10-01)

Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients
by: Juliana Cruz da Silva, et al.
Published: (2013-06-01)

Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study
by: Chien-Hsien Lo, et al.
Published: (2021-04-01)

Clinical Features and Outcome of SARS-CoV 2 Virus Infection in Patients with Autoimmune Diseases
by: Shahida Perveen, et al.
Published: (2022-11-01)

The place of hydroxychloroquine in modern dermatology
by: Aleksandra Dańczak-Pazdrowska, et al.
Published: (2021-08-01)

Complications in pregnant women with autoimmune diseases
by: J. Meneses-Calderón, et al.
Published: (2020-03-01)

New onset bullous lupus erythematosus in a systemic lupus erythematosus patient after initiation of hydroxychloroquin
by: Chanchal Gera, et al.
Published: (2014-01-01)

New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre
by: Rahana Abd Rahman, et al.
Published: (2020-12-01)

Autoimmune retinopathy associated with systemic lupus erythematosus: A diagnostic dilemma
by: Wadakarn Wuthisiri, et al.
Published: (2017-01-01)

Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine
by: Valentina Canti, et al.
Published: (2021-07-01)

Evaluation Incidence of Ocular Complications of Hydroxychloroquine and Related Risk Factors in Patients with Connective Tissue Disease Referred to the Rheumatology Clinic of Tohid Hospital in Sanandaj
by: Nasrin Moghimi, et al.
Published: (2023-03-01)

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
by: Noël Zahr, et al.
Published: (2021-03-01)

A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature
by: Daniel Kwak, et al.
Published: (2020-09-01)

Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus
by: Peng-Cheng Liu, et al.
Published: (2024-04-01)

Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions
by: Beibei Gao, et al.
Published: (2022-02-01)

SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
by: Pan Shen, et al.
Published: (2021-11-01)

A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2
by: Serban C. Musca
Published: (2020-08-01)

An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus
by: Atsushi Manabe, et al.
Published: (2024-04-01)

Epidemiology of the Epstein–Barr Virus in Autoimmune Inflammatory Rheumatic Diseases in Northern Brazil
by: Samires Avelino de Souza França, et al.
Published: (2022-03-01)

Lymphatic Function in Autoimmune Diseases
by: Noa Schwartz, et al.
Published: (2019-03-01)

Human T-Cell Lymphotropic Virus Type I (HTLV-1): implications for autoimmune diseases<br> Vírus linfotrópico de células T humano tipo 1 (HTLV-1): implicações em doenças autoimunes
by: Dênis Augusto Santana Reis, et al.
Published: (2012-06-01)

Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus
by: Karolina A. Englert, et al.
Published: (2023-11-01)

T Cells in Autoimmunity-Associated Cardiovascular Diseases
by: Daniella Muallem Schwartz, et al.
Published: (2020-10-01)

The relationship between hydroxychloroquine plasma concentration and COVID-19 outcomes in rheumatoid arthritis patients in Saudi Arabia
by: Ismail A. Walbi, et al.
Published: (2022-07-01)

A study to determine the effect of hydroxychloroquine (HCQ) on central corneal thickness (CCT) in patients with rheumatoid arthritis (RA)
by: Roshan Christina Jaichander, et al.
Published: (2024-01-01)

Analysis of Factors Influencing Whole Blood Hydroxychloroquine Concentration in Patients with Systemic Lupus Erythematosus in China
by: Xuan Huang, et al.
Published: (2023-09-01)

Hydroxychloroquine-induced generalized myopathy in a patient with lupus tumidus: a case report
by: Alice Verdelli, et al.
Published: (2023-10-01)

Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry
by: Chiharu Hidekawa, et al.
Published: (2023-09-01)

Identifying the differentially expressed microRNAs in autoimmunity: A systemic review and meta-analysis
by: Lian Zhang, et al.
Published: (2020-04-01)

Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines
by: April M. Jorge, et al.
Published: (2018-07-01)

The Effect of Hydroxychloroquine Treatment on Blood Sugar Level, Serum Lipid Profile and the Retina in Systemic Lupus Erythematosus Patients
by: Rania M. Sarhan, et al.
Published: (2016-03-01)

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
by: Ruth Fernandez-Ruiz, et al.
Published: (2020-08-01)

Gut dysbiosis in autoimmune diseases: Association with mortality
by: Sung-Ho Chang, et al.
Published: (2023-03-01)

Editorial: The role of monocytes/macrophages in autoimmunity and autoinflammation
by: Atsushi Kawakami, et al.
Published: (2022-11-01)

Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunityResearch in context
by: James I. Robinson, et al.
Published: (2022-12-01)

Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review
by: George Zarkavelis, et al.
Published: (2016-09-01)

A case of lupus erythematosus panniculitis misdiagnosed as vasculitis
by: Yuqi TANG, et al.
Published: (2023-04-01)

Circular RNAs: Potential biomarkers and therapeutic targets for autoimmune diseases
by: Ren-Jie Zhao, et al.
Published: (2024-01-01)

Neutrophil extracellular traps in autoimmune diseases: Analysis of the knowledge map
by: Wei Wang, et al.
Published: (2023-01-01)